GB9929569D0 - Therapeutic agents - Google Patents

Therapeutic agents

Info

Publication number
GB9929569D0
GB9929569D0 GBGB9929569.3A GB9929569A GB9929569D0 GB 9929569 D0 GB9929569 D0 GB 9929569D0 GB 9929569 A GB9929569 A GB 9929569A GB 9929569 D0 GB9929569 D0 GB 9929569D0
Authority
GB
United Kingdom
Prior art keywords
therapeutic agents
therapeutic
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9929569.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon Pharma UK Ltd
Original Assignee
Merck Sharp and Dohme Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp and Dohme Ltd filed Critical Merck Sharp and Dohme Ltd
Priority to GBGB9929569.3A priority Critical patent/GB9929569D0/en
Publication of GB9929569D0 publication Critical patent/GB9929569D0/en
Priority to EP00985541A priority patent/EP1242423A1/en
Priority to AU21954/01A priority patent/AU780554B2/en
Priority to CA002392955A priority patent/CA2392955A1/en
Priority to PCT/GB2000/004752 priority patent/WO2001044250A1/en
Priority to US10/149,852 priority patent/US7144887B2/en
Priority to JP2001544740A priority patent/JP2003516994A/ja
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GBGB9929569.3A 1999-12-14 1999-12-14 Therapeutic agents Ceased GB9929569D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB9929569.3A GB9929569D0 (en) 1999-12-14 1999-12-14 Therapeutic agents
EP00985541A EP1242423A1 (en) 1999-12-14 2000-12-11 SUBSTITUTED 1,2,3-TRIAZOLO 1,5-a]QUINAZOLINES FOR ENHANCING COGNITION
AU21954/01A AU780554B2 (en) 1999-12-14 2000-12-11 Substituted 1,2,3-triazolo(1,5-a)quinazolines for enhancing cognition
CA002392955A CA2392955A1 (en) 1999-12-14 2000-12-11 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
PCT/GB2000/004752 WO2001044250A1 (en) 1999-12-14 2000-12-11 SUBSTITUTED 1,2,3-TRIAZOLO[1,5-a]QUINAZOLINES FOR ENHANCING COGNITION
US10/149,852 US7144887B2 (en) 1999-12-14 2000-12-11 Substituted 1,2,3-triazolo[1,5-a]quinazolines for enhancing cognition
JP2001544740A JP2003516994A (ja) 1999-12-14 2000-12-11 認知能力を向上させるための置換１，２，３−トリアゾロ［１，５−ａ］キナゾリン

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9929569.3A GB9929569D0 (en) 1999-12-14 1999-12-14 Therapeutic agents

Publications (1)

Publication Number Publication Date
GB9929569D0 true GB9929569D0 (en) 2000-02-09

Family

ID=10866311

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9929569.3A Ceased GB9929569D0 (en) 1999-12-14 1999-12-14 Therapeutic agents

Country Status (7)

Country Link
US (1) US7144887B2 (enExample)
EP (1) EP1242423A1 (enExample)
JP (1) JP2003516994A (enExample)
AU (1) AU780554B2 (enExample)
CA (1) CA2392955A1 (enExample)
GB (1) GB9929569D0 (enExample)
WO (1) WO2001044250A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0108475D0 (en) * 2001-04-04 2001-05-23 Merck Sharp & Dohme New compounds
EP2321285A1 (en) 2008-07-28 2011-05-18 F. Hoffmann-La Roche AG Diazepan and piperazine derivatives modulators of chemokine receptors
AU2011328993B2 (en) 2010-11-15 2017-03-02 Agenebio, Inc. Pyridazine derivatives, compositions and methods for treating cognitive impairment
MX2013005443A (es) * 2010-11-15 2013-10-07 Agenebio Inc Derivados de benzodiazepina, composiciones y metodos para tratar el deterioro cognitivo.
US20150374705A1 (en) 2012-02-14 2015-12-31 Shanghai Institues for Biological Sciences Substances for treatment or relief of pain
CN104363908B (zh) * 2012-05-30 2017-12-22 霍夫曼-拉罗奇有限公司 吡咯烷基杂环类
EP4032889B1 (en) 2013-12-20 2026-05-06 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
EP3310785B1 (en) 2015-06-19 2024-11-20 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
CN107344937A (zh) * 2016-05-06 2017-11-14 如东赛默罗生物科技有限公司 三唑并[1,5-a]喹唑啉类衍生物、其制备方法、药物组合物和用途
US20180170941A1 (en) 2016-12-19 2018-06-21 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment
AU2019288382B2 (en) 2018-06-19 2024-07-25 Agenebio, Inc. Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH21834A (en) 1982-01-18 1988-03-17 Lepetit Spa New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
US5306819A (en) 1992-08-27 1994-04-26 Neurogen Corporation Certain aryl a cycloalkyl fused imidazopyrazinols; and new class of GABA brain receptor ligands
DE19617862A1 (de) * 1996-04-23 1997-10-30 Schering Ag Phthalazinderivate, deren Herstellung und Verwendung als Arzneimittel
EP0915875B1 (en) 1996-07-25 2003-04-09 MERCK SHARP & DOHME LTD. Substituted triazolo-pyridazine derivatives as ligands for gaba receptors
WO1998050385A1 (en) * 1997-05-08 1998-11-12 Merck Sharp & Dohme Limited SUBSTITUTED 1,2,4-TRIAZOLO[3,4-a]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS
GB9813006D0 (en) * 1998-06-16 1998-08-12 Merck Sharp & Dohme Therapeutic agents
GB9929687D0 (en) * 1999-12-15 2000-02-09 Merck Sharp & Dohme Therapeutic agents

Also Published As

Publication number Publication date
AU780554B2 (en) 2005-03-24
AU2195401A (en) 2001-06-25
US7144887B2 (en) 2006-12-05
US20030125333A1 (en) 2003-07-03
EP1242423A1 (en) 2002-09-25
JP2003516994A (ja) 2003-05-20
WO2001044250A1 (en) 2001-06-21
CA2392955A1 (en) 2001-06-21

Similar Documents

Publication Publication Date Title
GB9911863D0 (en) Therapeutic agents
GB9905010D0 (en) Therapeutic agents
IL150030A0 (en) Therapeutic agents
GB9820113D0 (en) Therapeutic agents
GB9904786D0 (en) Therapeutic agents
GB9929685D0 (en) Therapeutic agents
GB9929687D0 (en) Therapeutic agents
GB9921351D0 (en) Therapeutic agents
GB9911881D0 (en) Therapeutic agents
GB9903476D0 (en) Therapeutic agents
GB9813006D0 (en) Therapeutic agents
PL339848A1 (en) Therapeutic agent against hypephosphataemia
AP9901436A0 (en) Therapeutic agents
GB9801210D0 (en) Therapeutic agents
GB9911802D0 (en) Therapeutic combination
GB9914745D0 (en) Therapeutic agents
GB9911803D0 (en) Therapeutic combination
GB9914744D0 (en) Therapeutic agents
GB9911804D0 (en) Therapeutic combination
GB9801202D0 (en) Therapeutic agents
GB9903119D0 (en) Therapeutic agents
GB9914742D0 (en) Therapeutic agents
GB9902881D0 (en) Therapeutic agents
GB9914743D0 (en) Therapeutic agents
GB9911238D0 (en) Therapeutic use

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)